12.1
ENDRA Life Sciences Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
5.38
FY23:
3.03
FY24:
3.43
FY25:
0.97
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.78
FY22:
3.89
FY23:
3.72
FY24:
1.02
FY25:
2.89
Total assets
Change from FY21 to FY25
millions USD
FY21:
12.9
FY22:
9.27
FY23:
6.75
FY24:
4.45
FY25:
3.85
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.54
FY22:
1.70
FY23:
0.90
FY24:
0.61
FY25:
0.75
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
0.37
FY23:
0.19
FY24:
1.29
FY25:
0.84
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.8
FY22:
7.20
FY23:
5.66
FY24:
2.56
FY25:
2.26
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
12.9
FY22:
9.27
FY23:
6.75
FY24:
4.45
FY25:
3.85
All amounts in millions USD